Back to Search
Start Over
Isolated hypomagnesemia in a patient treated with capecitabine.
- Source :
-
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2013 Sep; Vol. 19 (3), pp. 254-6. Date of Electronic Publication: 2012 Sep 04. - Publication Year :
- 2013
-
Abstract
- Hypomagnesemia is known to occur for a variety of renal, gastrointestinal and other causes, and is often associated with other electrolyte and metabolic disturbances. We present a case of isolated hypomagnesemia in a patient who had been treated with the chemotherapy agent capecitabine. The approach to diagnosis and treatment is discussed. We postulate that capecitabine may cause isolated hypomagnesemia, possibly due to renal magnesium loss.
- Subjects :
- Capecitabine
Deoxycytidine adverse effects
Deoxycytidine therapeutic use
Female
Fluorouracil adverse effects
Fluorouracil therapeutic use
Humans
Hypercalciuria metabolism
Magnesium metabolism
Middle Aged
Nephrocalcinosis metabolism
Renal Tubular Transport, Inborn Errors metabolism
Deoxycytidine analogs & derivatives
Fluorouracil analogs & derivatives
Hypercalciuria chemically induced
Nephrocalcinosis chemically induced
Renal Tubular Transport, Inborn Errors chemically induced
Subjects
Details
- Language :
- English
- ISSN :
- 1477-092X
- Volume :
- 19
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
- Publication Type :
- Academic Journal
- Accession number :
- 22948887
- Full Text :
- https://doi.org/10.1177/1078155212455445